A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...

Investigators at Mass General Brigham have developed a tool that can identify older adults at increased risk of emergency healthcare needs, rehospitalization or death. The tool measured patient ...

Authorship: In addition to Aronson, Blood, and Unlu, Mass General Brigham authors include Matthew Varugheese ... Corcept Therapeutics, Nference Inc, Withings, and Arsenal Capital Partners and having ...

The city put out a Request for Proposals (RFP) last December asking for “proposals from qualified owners” willing to lease ...

Good morning, Boston. Are you enjoying this warmer weather? I grilled hamburgers and a steak for dinner last night, and it was great. Here are the five things you need to know in local business news ...

Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc. (“OrphAI”), a clinical-stage biopharmaceutical ... He has a dual appointment at Mass General Brigham in Cardiovascular Medicine and Pulmonary ...

Boston’s Mass General Brigham Inc. will settle a proposed class action challenging its retirement plan fees after failing to secure an immediate appeal of a decision allowing the case to advance. The ...

BTB Therapeutics, Inc., a clinical-stage drug development company developing ... Autologous Biomanufacturing Cellino today announced its collaboration with Mass General Brigham's Gene and Cell Therapy ...

Pope Francis had coffee and was reading newspapers Saturday after an alarming setback in his two-week recovery from double ...

A fight over the future of cancer care is playing out in a behind-the-scenes battle over Dana-Farber Cancer Institute’s ...

A review of the transaction’s cost and market impact by the Massachusetts Health Policy Commission, released Thursday, raises ...